About this trial
This randomized clinical trial evaluates the effects of photobiomodulation with a superpulsed diode laser (810 + 980 nm) on orofacial pain and tension-type headache in children and adolescents. Sixty participants will be assigned to receive active PBM or sham therapy over eight sessions. Pain and anthropometric variables will be assessed.
Eligibility criteria
Qualifiers
Children and adolescents 6 to 17 years of age enrolled at the medical and dental clinic of Universidade Nove de Julho (UNINOVE), Vergueiro Campus;
Children and adolescents who present with at least one symptom of orofacial pain and/or headache, according to the Faces Pain Scale and the childhood and adolescence headache questionnaire based on the ICHD-3
Disqualifiers
Pregnant adolescents;
Having taken corticoids, non-steroidal anti-inflammatory drugs or analgesics in the previous 30 days;
Having taken isotretinoin;
Individuals who report photosensitivity to laser or LED in previous treatments.
Trial design
Treatments tested in this trial
- Active Photobiomodulation
- Sham Photobiomodulation